Adamis Pharmaceuticals Corporation
San Diego, CA, United States
This page shows every FDA and USDA recall linked to Adamis Pharmaceuticals Corporation. Each entry includes the product involved, when the recall happened, and how serious it was. If a company has had multiple recalls over the years, you can see the full history here in one place — including whether any were Class I, which is the most serious type.
1
Total Recalls
2022
First Recall
2022
Most Recent
1
Class I (Most Serious)
SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton,...
Apr 13, 2022
· Drug
Class I
Terminated